Inhibition of HIF1α, a key TF in Th17/Treg reciprocal differentiation, by Echinomycin (NSC-13502) was shown to efficiently attenuate GVHD and preserve anti-leukemic activity by inducing Treg expansion while diminishing Th17 responses (229). This evidence concerns the gene TF and graft versus host disease.